Holen Sie sich die Stockscreener-App
14.72
5.00%
-0.7753
Handel nachbörslich:
14.85
0.1253
+0.85%
Schlusskurs vom Vortag:
$15.50
Offen:
$15
24-Stunden-Volumen:
628
Relative Volume:
0.24
Marktkapitalisierung:
$123.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-7.22%
1M Leistung:
+9.07%
6M Leistung:
+7.64%
1J Leistung:
+0.00%
1-Tages-Spanne:
$14.72
$15.00
1-Wochen-Bereich:
$14.72
$16.00
52-Wochen-Spanne:
$8.86
$22.63
Exozymes Inc Stock (EXOZ) Company Profile
Firmenname
Exozymes Inc
Sektor
Branche
Telefon
(626) - 415 - 1488
Adresse
750 ROYAL OAKS DR, MONROVIA
Vergleichen Sie EXOZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
14.72 | 125.81M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Exozymes Inc Aktie (EXOZ) Neueste Nachrichten
What Technical Tools Say About Ceigall India Limited RecoveryDividend Yield Trends & Small Capital Trading Tips - earlytimes.in
Gains Report: Can Hudson Global Inc. (HDH1) stock sustain institutional flowsRate Cut & Step-by-Step Swing Trade Plans - BỘ NỘI VỤ
Comparing eXoZymes (EXOZ) & Its Competitors - Defense World
Big Money Moves: Will eXoZymes Inc. stock keep outperforming rivalsMarket Sentiment Summary & Daily Stock Trend Reports - BỘ NỘI VỤ
What is the fair value of eXoZymes Inc. stock nowJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - BỘ NỘI VỤ
Will eXoZymes Inc. stock keep outperforming rivalsTrade Analysis Summary & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
Downgrade Watch: Can NVTX stock ride next bull market cycleTrade Volume Report & Free Growth Oriented Trading Recommendations - BỘ NỘI VỤ
Breakout Move: Why Bioceres Crop Solutions Corp. stock could be next big winner - BỘ NỘI VỤ
Is eXoZymes Inc. stock attractive for retirement portfolios2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
eXoZymes Inc trading resumes - MSN
eXoZymes Inc trading halted, volatility trading pause - MSN
LA Weekly: The Enzyme Frontier - marketscreener.com
Will eXoZymes Inc. stock reach Wall Street targetsJobs Report & Risk Controlled Swing Alerts - newser.com
Is eXoZymes Inc. stock gaining market share2025 Short Interest & Community Consensus Picks - newser.com
What analyst consensus says on eXoZymes Inc. stock - newser.com
Tools to monitor eXoZymes Inc. recovery probabilityQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Why eXoZymes Inc. stock is a must watch in 20252025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com
Heatmap analysis for eXoZymes Inc. and competitorsTrade Exit Report & Fast Exit Strategy with Risk Control - newser.com
Slack Capital report: EXOZ is a once-in-a-lifetime opportunity - marketscreener.com
How eXoZymes Inc. stock performs in weak economy2025 Price Momentum & High Return Stock Watch Alerts - newser.com
Published on: 2025-11-16 04:36:16 - newser.com
Order flow analysis tools used on eXoZymes Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
eXoZymes Releases Updated Investor Presentation - MSN
Can technical indicators confirm eXoZymes Inc.’s reversal2025 Analyst Calls & Daily Profit Maximizing Trade Tips - newser.com
Exozymes Inc. Reports Significant Losses Amid Financial Challenges - MSN
How to use Fibonacci retracement on eXoZymes Inc.Weekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Finanzdaten der Exozymes Inc-Aktie (EXOZ)
Es liegen keine Finanzdaten für Exozymes Inc (EXOZ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Exozymes Inc-Aktie (EXOZ) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 17 '25 |
Buy |
10.78 |
1,767 |
19,048 |
3,872 |
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):